The effects of calcium sodium ethylenediaminetetra-acetate (CaNa2EDTA) on the kinetics of distribution and excretion of lead (210Pb) have been studied in rats. When the chelant was given intravenously, at 50 mg./rat daily after a single intravenous injection of 100 ,ug. lead/rat, it greatly increased the urinary excretion of lead but reduced the faecal excretion. The greatest effects occurred in the rats treated with chelant shortly after the lead injection. When the chelant was given seven or more days after the lead the increase in lead excretion was negligible. CaNa2EDTA mobilized lead from every tissue, but the kinetic analysis of the disappearance of 210Pb showed the presence of two elimination phases. Lead ions weakly bound to the cells were rapidly removed by EDTA, whereas the lead fixed to endocellular constituents Was only slowly removed. The chelant did not mobilize lead from bone.
Ethylenediaminetetra-acetic acid (EDTA) is widely used in the prevention and treatment of lead poisoning for its property of binding pb+t ions and so forming a relatively stable and non-toxic complex. Since EDTA may form complexes with other ions, in practice the drug is given as its calcium chelate (CaNa2EDTA) to prevent loss of calcium from the body.
The EDTA has been given by different routes: 'intravenous, oral, and aerosol inhalation (Kehoe, 1955; Zambrano and Rossi, 1955;  Teisinger and Srbova, 1956; Bell, Gilliland, Boland and Sullivan, 1956; Bastenier, Deslypere, and de Graef-Millet, 1958; Desoille, Albahary, Truhaut, and Boudene, 1958; Petrovic, Stankovic, Savi&evic, and Poleti, 1960; Albahary, Truhaut, Boudene, and Desoille, 1961; Williams, Matthews, and Judd, 1962; Castellino and Grieco, 1964) . The work of these authors, among others, shows that lead excretion is increased after EDTA administration, but where and how rapidly lead is mobilized is not satisfactorily known.
The metabolism of EDTA labelled with 14C has been studied in rats and in man by Foreman, Vier, and Magee (1953) and by Foreman and Trujillo (1954) . After parenteral injection, Ca14C-EDTA spreads rapidly from the vascular system and is not concentrated in any tissue. The compound is rapidly and totally excreted through the kidneys, and after six hours 95% to 98% of the dose is found in the urine. The compound is poorly absorbed by the gastro-intestinal tract (in the rat a maximum of 18 %; in man a maximum of 5 %) and not at all through the skin. The low intestinal absorption of CaNa2EDTA has been confirmed by Srbova and Teisinger (1957) , who found only 16-6 % and 2-6 % was absorbed in the rat and in man respectively. Teisinger, Lustinec, and Srbova (1958a) studied the effects of CaNa2EDTA by liver perfusion in a normal and a poisoned cat, and Teisinger, Zumanova, and Zezula (1958b) (Castellino and Aloj, 1964 3, 6, 8, 10, and 12 days.
In the sixth group treatment with CaNa2EDTA was started seven days after the lead injection and was repeated in three cycles of three daily injections each until the animals were killed on the twenty-third day.
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Oral Administration ofLead Acetate and CaNa2EDTA.
-In two groups of five rats each, 500 ,tg. lead/rat was given. The rats were killed 24 hours later. The first group of rats was treated a few days before and during the experiment with CaNa2EDTA administered ad libitum as a 1 % solution in the drinking water. The second group was not treated with chelant and was kept as a control.
Sampling.-During the experiments all the rats were kept in individual metabolism cages for separate collection of urine and faeces. Faeces and urine were collected, and the faeces were dried for 24 hours at 100'C. and then pulverized. The rats were killed by blood-letting. Blood was taken by heart puncture with a heparinized syringe. A portion was centrifuged and separated into plasmatic and cellular components.
The following tissues were obtained at necropsy: striated muscle, liver, kidneys, lungs, spleen, heart, and femur.
In the animals treated orally with lead the whole gastrointestinal tract was taken and hydrolysed in hot NaOH (33 % by wt.).
The analytical methods and the kinetic analysis were as given in our previous paper (Castellino and Aloj, 1964) .
Results

Intravenous Injection of Lead Acetate followed by Intravenous Administrations of CaNa2EDTA
Treatment with CaNa2EDTA Starting 24 hours after Lead.- Table 1 gives the 210Pb concentrations/g. of fresh tissue and their variation with time. The highest values were found in the bone, renal and hepatic tissues and, in decreasing order, in the splenic, pulmonary, cardiac, and striated muscle tissues.
In the blood, lead was mainly bound to the cells and more than 100% was found in the plasma only at the beginning of the treatment with chelant. These initial high plasma concentrations resulted from the massive removal of lead ions from the tissue into the plasma when CaNa2EDTA was first administered. The total lead contents of whole organs were calculated, and the kinetics of 210Pb disappearance are shown in Figures 1 to 6. In these figures the experimental points corresponding to 1, 12, and 24 hours are taken from the previous paper on control rats (Castellino and Aloj, 1964) .
For all the tissues that have been examined, the concentrations of 210Pb remaining in them could be expressed by a sum of only two exponential terms, i.e., in the treated rats the two initial phases of 210Pb removal observed in controls were blended into one with a biological half life of eight to 12 hours. In both controls and treated animals a slow final phase followed. Disappearance at this stage was rather faster in the treated rats (half life 53 to 216 hours) than in the controls (half life 192 to 610 hours). Thus the lead which was readily mobilized was rapidly removed by EDTA, whereas the removal of the rest, probably corresponding to the more stable endogenous lead complexes, was only indirectly and slightly accelerated. CaNa2EDTA did not mobilize the lead from bone, in which the concentration of the metal remained unchanged during the whole period of treatment.
The excretion of lead after the administration of CaNa2EDTA is shown in Figure 7 . Compared with the controls (Castellino and Aloj, 1964) , CaNa2-EDTA significantly increased the excretion of lead in the urine but decreased excretion in the faeces. The greatest effect was observed after the first administration of the chelant, and urinary lead reached its maximum at 48 hours. Over the whole 12-day period of treatment, 38 % of the dose (fiducial limits 31-70% to 447%) was excreted by urine and 23 % (fiducial limits 15 6% to 29 8%) was excreted by faeces. The total excretion, 61 %, was not significantly higher than from the controls.
Treatment with CaNa2EDTA Starting Seven Days after Lead Injection.-In Table 2 the 210Pb in various tissues of treated rats is compared with the 210Pb in the same tissues of controls 23 days after the injection of 210Pb. The concentrations in the controls were calculated by extrapolating the curves in the preceding paper. CaNa2EDTA removed some lead from all tissues except bone. Table 3 shows that CaNa2EDTA slightly increased the urinary elimination of lead without modifying that in the faeces. Thus administration of EDTA when the slow removal phase of lead was predominant resulted in negligible mobilization of lead.
Oral Administration of Lead Acetate and CaNa2EDTA. -Tables 4 and 5 show the results obtained in two groups of rats, one of which had been treated with CaNa2EDTA.
In both groups, the percentages of 210Pb absorbed through the intestine, excreted by faeces, and found in the gastro-intestinal tract were similar. In contrast, rats treated with CaNa2EDTA contained less 210Pb fixed in soft tissues and in bone (p < 001) and fluids and before they could be fixed in the bone. These experiments indicated that lead absorbed through the intestine was not concentrated in the liver but was distributed throughout the whole organism; and that treatment with CaNa2EDTA by mouth did not modify the intestinal absorption of lead but increased its elimination in urine.
Discussion
The results showed that CaNa2EDTA mobilized lead from all tissues with the exception of the bone. Lead, chelated in the EDTA molecule, passed into the plasma and was rapidly excreted by the kidney.
As the Pb-EDTA complex is excreted by the same route as EDTA itself, some lead ions, bound in the liver and in other parts of the body, were no longer excreted via the bile in faeces but were eliminated instead in the urine. This was shown by the increase in urinary excretion accompanied by a decrease in faecal excretion.
The kinetics of 210Pb removal from the different tissues explain the action of CaNa2EDTA and confirm the complexity of lead metabolism. Since the disappearance of 210Pb in rats given EDTA still required two exponential terms for its expression, it seems that CaNa2EDTA accelerated the removal of lead without modifying its metabolism. Weakly bound or extracellular lead was rapidly removed, but lead strongly complexed inside the cells was still removed only very slowly. It seems unlikely that such acceleration as there was of this slow phase was brought about by any direct action of the chelant on lead in the cells. It is more likely that, by removing some of the extracellular lead, it increased the rate of transport out of the cells by increasing the concentration gradient. This hypothesis is confirmed by the results obtained in the rats treated with CaNa2-EDTA some days after lead injection, when the rapid phases of 210Pb disappearance were over. In these animals CaNa2EDTA had only a slight effect on the excretion of lead and on the percentages of metal fixed in the tissues. We therefore agree with Teisinger et al. (1958a, b) that CaNa2EDTA passes into the extravascular space where it binds lead ions, but does not penetrate the cells.
CaNa2EDTA did not mobilize lead from bone, in which probably the metal, bound to other ions, is fixed as a stable organic compound. Previous researches showed that there are analogies between calcium and lead metabolism in the bone (Nishimura, 1957) , and that lead is fixed by the osteons (Vincent, 1957) . Discordant views, however, have been expressed on the possibilities of modifying the fixation of lead in bone. Some authors (Hunter and Aub, 1927; Nishimura, 1957) think that parathyroid hormones modify the fixation of lead in bone, wheras Calhoun, McLean, Hudson, and Aub (1954) found that neither a low nor a high calcium diet, nor parathyroid hormones, affected lead excretion. This problem needs further study. Our experiments showed that CaNa2EDTA lowered lead deposition only when the chelant was given before lead and are in agreement with previous work on the mobilization of radioactive metals with chelating agents by Foreman, Fuqua, and Norwood (1954) and by Catsch (1961) and Catsch and Schindewolf-Jordan (1961) .
Finally, it has been supposed that the oral use of EDTA could increase the intestinal absorption of lead. The increase in urinary lead excretion would then depend on its higher absorption by the intestine and its more rapid removal out of the tissues. Our experiments show that the oral administration of CaNa2EDTA caused a great increase of urinary lead excretion without modifying its intestinal absorption: about 18 % of the lead was absorbed by rats whether they were treated with EDTA or not.
